The paradox here is that Botanix isn't actually a cannabis stock. I acknowledge that the legal roadmap for cannabis based medicines and synthetic cannabinoid based medicines overlaps and also that BOT can hitch a ride on the cannabis investment trail. It doesn't really matter. What I have my eye on now is the commencement of the Phase 2 Acne Trial.
I anticipate that the plant based medicines will need to follow synthetic medicines through the door to full legal acceptance.
I am yet to find someone with a reasoned argument against CBD. It doesn't give anyone a high and is about as illicit as hemp rope.
cheers
Med-Cannabis2018, page-5
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.005(1.54%) |
Mkt cap ! $581.5M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.0¢ | 32.0¢ | $1.058M | 3.280M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 147750 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 632850 | 6 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |